Skip to main content
. 2018 Oct 4;9:1021. doi: 10.3389/fphar.2018.01021

Figure 8.

Figure 8

Effects of the pretreatment with anti-IL17 on (A) CD4+ and (B) FOXP3-positive cells in lung tissue. *P < 0.05 compared to the SAL and SAL-antiIL17 groups; **P < 0.05 compared to the LPS group.